OptimizeRx Corporation (OPRX) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$9.41 +0.97% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $9.45

OptimizeRx Corporation (OPRX) earns a Roarable Rating of B- (Buy) with 71/100 RQD Confidence. High-quality cash engine (67% profit margin, 7% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B- β€’ BUY Cap $175.6M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on OPRX Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is OPRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, OptimizeRx Corporation (NASDAQ: OPRX) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $9.41 (+0.97% 1D, market cap $175.6M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 15/20. Across 1011 tracked Consumer Discretionary issuers, OPRX ranks #145 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does OPRX compare to UXIN and DHX in the Consumer Discretionary sector?
β–Ό

Within the Consumer Discretionary sector (Business Services), OPRX carries a Roarable B- (71/100 RQD), trailing P/E of 34.4x, gross margin of 67.3%, and ROIC of 7.3%. By comparison, UXIN (Uxin Limited ADS) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $195.8M) and DHX (DHI Group Inc.) posts a D grade (51/100 RQD, P/E N/A, ROIC -7.4%, cap $196.3M). Among the 5-stock peer group, OPRX leads on earnings multiple (34.4x) while OPRX leads on capital efficiency (7.3% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for OPRX?
β–Ό

Per OPRX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001448431), OptimizeRx Corporation generated $109.4M in revenue (+18.8% YoY), $5.1M in net income, and $18.7M in free cash flow against $176.9M in total assets and $21.4M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $9.45 (+0.41%)🧬 Cannibal Buyback (-2.08% YoY Shares)βš™οΈ Cash Engine: 14/20 (B-) β€’ 17% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 71/100 (B-) historically ranked in the Top 14% of excess returns over the next 90 days (+6.8% avg 90D alpha vs SPY β€’ 68.4% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERBUY β€’ B-
025507510071
3-of-3 JEV AI Jury Bullish
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ Β· Rk B
Cash (14)Whales (12)SEC (14)Macro (16)CEO (15)
Each axis scored 0–20
12M PRICE TARGET CONE+5.8% Base Target
$22 Bull$10 Base$8 Bear
πŸ“¬ FREE OPRX RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for OPRX)Realized 20D OHLCV Swing Band: Β±9.9%
Deterministic 5-Pillar Attribution (71/100 Composite)
πŸ” WHY OPRX SCORES 71/100 (B-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: Macro Regime Fit+16/20 pts (23% of score)

FRED Regime Γ— Technicals: 29% of 52W Range β€’ RSI-14 at 62.9 (BULLISH MOMENTUM)

β–² #2 Bullish Driver: Insider Conviction & Share Dilution+15/20 pts (21% of score)

SEC Form 4 / 13F Thermometer: 75% Net Buy β€’ Cannibal Buyback (-2.08% YoY Shares)

β–Ό #1 Drag / Risk Factor: Whale & Options Positioning12/20 pts (-8 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-8 pts vs max)

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
63
Grade C+$8.43+5.9% Next Q
Q2 (-2Q)
66
Grade B-$8.93+1.5% Next Q
Q3 (-1Q)
68
Grade B-$9.06+3.9% Next Q
Current
71
Grade B-$9.41+6.8% Hist 90D Ξ±
Trajectory: C+ (63) β†’ B- (71)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the OPRX Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 71/100 (B-) score, OPRX faces multiple-compression risk if 34.4x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-2.08% YoY Shares) β€” any gross margin slip below 64.8% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($8.27) or 200D SMA ($7.27) invalidates the momentum regime and cuts Target Base ($9.96) toward Bear Floor ($7.72).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $OPRXβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œOPRX Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

OPRX Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (OPRX)

No recent open-market Form 4 cluster sales or emergency dumps flagged on OPRX. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (OPRX Tape Review)

  • βœ“Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • βœ“Forensic Red-Light accounting & dilution traps to review on your watchlist
  • βœ“Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
OPRX // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +39.00%β–² ASCENDING CHANNEL
2026-11-03O $9.37H $9.41L $9.32C $9.41VOL 136.6K
RES: $9.93SUP: $8.41SMA50: $8.27SMA200: $7.27
$13.69$11.21$8.73$6.25$3.77RES $9.93SUP $8.41$9.412026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

OPRX Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
26.5%/yr Implied 5Y Growth

vs. +18.8% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on OPRX today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for OPRX. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for OPRX today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (OPRX)

Consumer Discretionary Rank #145 of 1011 βš”οΈ UXIN vs OPRX Full Matrix β†’

1. Head-to-Head Consumer Discretionary Peer Comparison (OPRX vs. UXIN, DHX, AMWL, CURR)

Industry: Business Services (90 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, OptimizeRx Corporation (OPRX) ranks #145 by composite RQD confidence (71/100, grade B-) and #705 by equity capitalization ($175.6M). Within this direct 5-issuer industry benchmark cohort, OPRX leads on earnings valuation at 34.4x trailing P/E, while OPRX leads on capital efficiency and profitability with 7.3% ROIC and 67.3% gross margin. OPRX currently leads its immediate peer cohort in composite quantitative strength at 71/100 (B-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
OPRX ACTIVE
OptimizeRx Corporation
B- 71/100 34.4x 67.3% 7.3% +0.97% $175.6M Benchmark Subject
UXIN
Uxin Limited ADS
E 29/100 β€” 6.7% -35.0% +1.79% $195.8M /uxin-vs-oprx β†’
DHX
DHI Group Inc.
D 51/100 β€” 84.7% -7.4% +5.75% $196.3M /dhx-vs-oprx β†’
AMWL
American Well Corporation (Class A)
D- 39/100 β€” β€” -35.0% -1.65% $216.5M /amwl-vs-oprx β†’
CURR
Currenc Group Inc.
E 31/100 β€” 40.8% -35.0% -8.96% $238.0M /curr-vs-oprx β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001448431

In its most recent audited fiscal period (FY2025, filed 2025-12-31), OptimizeRx Corporation (OPRX) reported GAAP revenue of $109.4M (+18.8% vs. FY2024 revenue of $92.1M , and +53.0% cumulative change since FY2023) , GAAP net income of $5.1M, operating cash flow of $18.7M, and free cash flow of $18.7M (+290.6% YoY). On the balance sheet, OPRX closed FY2025 with $176.9M in total assets against $21.4M in total debt (Altman Z-Score: 2.68, Piotroski F-Score: 9/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $109.4M $5.1M $18.7M $18.7M $176.9M $21.4M
FY2024 (FY) 2024-12-31 $92.1M -$20.1M $4.9M $4.8M $171.2M $30.8M
FY2023 (FY) 2023-12-31 $71.5M -$17.6M -$7.2M -$7.2M β€” β€”

3. OPRX Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is OPRX stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, OptimizeRx Corporation (NASDAQ: OPRX) is rated B- (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 71/100 at a spot price of $9.41 (+0.97% 1D, market cap $175.6M). Pillar breakdown: Fundamental Cash Engine 14/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 14/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 15/20. Across 1011 tracked Consumer Discretionary issuers, OPRX ranks #145 in composite RQD confidence.

How does OPRX compare to UXIN and DHX in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Business Services), OPRX carries a Roarable B- (71/100 RQD), trailing P/E of 34.4x, gross margin of 67.3%, and ROIC of 7.3%. By comparison, UXIN (Uxin Limited ADS) holds a E grade (29/100 RQD, P/E N/A, ROIC -35.0%, cap $195.8M) and DHX (DHI Group Inc.) posts a D grade (51/100 RQD, P/E N/A, ROIC -7.4%, cap $196.3M). Among the 5-stock peer group, OPRX leads on earnings multiple (34.4x) while OPRX leads on capital efficiency (7.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for OPRX?

Per OPRX's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001448431), OptimizeRx Corporation generated $109.4M in revenue (+18.8% YoY), $5.1M in net income, and $18.7M in free cash flow against $176.9M in total assets and $21.4M in total debt. Key quantitative strengths: Company leadership has skin in the game with net positive insider conviction.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is OPRX trading relative to its 50-day, 200-day, and 52-week technical levels?

OPRX last traded at $9.41 (+0.97% on volume of 148,290 shares), positioning the stock +13.78% above its 50-day simple moving average ($8.27) and +29.44% above its 200-day simple moving average ($7.27). Across its 52-week range of $4.54 to $21.09, OPRX sits at the 29.4% percentile with a 14-day RSI of 62.9 (BULLISH MOMENTUM) and an implied next-earnings move of Β±9.9% ($8.48 to $10.34).

ROARABLE RATING BRIEF β€’ RQD 71/100 (B-) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

OPRX β€” OptimizeRx Corporation: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:41:59Z

1. Roarable Rating Brief: What This Means to a Prospective Investor

OPRX scores 71 out of 100, graded B- and labeled "Roarable Buy β€” Sound Institutional Accumulation." The five pillars are:

  • Fundamental Cash Engine: 14 / 20. Per the RQD rating, this reflects ROIC of 7.3% and an FCF yield of 10.57%. For an investor, the FCF yield signals that the business generates meaningful cash relative to its market value, while the modest ROIC indicates capital is not yet compounding at a high rate.
  • Whale 13F Flow: 12 / 20. Per the RQD rating, this pillar captures institutional accumulation and options positioning. The score is the lowest of the five, so institutional support is present but not the strongest signal in the rating.
  • Insider Conviction: 15 / 20. Per the RQD rating, this reflects SEC Form 4 and Congressional PTR cluster flow.
  • Macro Regime Fit: 16 / 20. Per the RQD rating, beta is 1.0 with sector sensitivity noted. This is the strongest pillar, suggesting market-level risk is roughly in line with the broader market.
  • Forensic Balance Sheet: 14 / 20. Per the RQD rating, Altman Z is 2.68, Piotroski F is 9/9, and Debt/Equity is 0.17. The strong Piotroski reading and low leverage are supportive; the Altman Z sits in a range that warrants monitoring rather than comfort.

Investor implications, framed analytically: upside drivers in the data include the high FCF yield, strong Piotroski reading, low leverage, and the recent turn to positive FY 2025 net income. The valuation tradeoff is visible in the multiples: P/E (TTM) of 34.4 and EV/EBITDA of 14.9 against an EPS (TTM) of 0.27 and a 52-week range of $4.54 to $21.09, which shows the stock has moved sharply in both directions over the past year. The price of 9.37 sits well below the 52-week high, which is a fact about price history and not a judgment on value.

2. Business Model, Unit Margins & SEC Financial Trajectory

Sector is Consumer Discretionary and industry is Business Services, listed on NASDAQ. The profile section does not describe the company's products, customers, or revenue model. Gross margin is 67.3%, operating margin is 10.7%, and net margin is 4.7%.

Section:

Revenue grew from $71.5M in FY 2023 to $109.4M in FY 2025, and the company moved from operating losses to positive operating income of $11.7M in FY 2025. Operating margin is 10.7% and net margin is 4.7%. Per the RQD rating, ROIC is 7.3%, Altman Z is 2.68, and Piotroski F is 9/9. Debt fell from $30.8M to $21.4M over FY 2024 to FY 2025, and Debt/Equity is 0.17 per the RQD rating.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case: Revenue rose from $71.5M in FY 2023 to $109.4M in FY 2025 while operating income turned positive at $11.7M, supported by a 10.57% FCF yield and a Piotroski F-Score of 9/9. With Fundamental Cash Engine at 14/20 (ROIC 7.3%, FCF yield 10.57%) and Institutional Whale Flow at 12/20, sustained execution supports upside toward the top of the $4.54 – $21.09 52-week range.
  • 🐻 Primary Bear Case: The stock trades at a P/E (TTM) of 34.4 and EV/EBITDA of 14.9 on EPS (TTM) of 0.27, with an Altman Z-Score of 2.68 and ROIC of only 7.3%. Investors must weigh 34.4x trailing P/E and 14.9x EV/EBITDA against 10.7% operating margins and a 1.00 macro beta if sector demand softens.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Operating in Business Services (Consumer Discretionary), OPRX carries a macro regime beta of 1.00 and gross margin of 67.3%.

  • Key Question #1: What specific products and customers generate the $109.4M of FY 2025 revenue, and what drove the swing from operating losses to operating income?
  • Key Question #2: What were the results of the third-quarter report referenced in the news wire, and how do they compare with the FY 2025 trend?
  • Key Question #3: What does the Trade Desk integration mean for revenue, and is it expected to contribute materially?

OPRX Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for OptimizeRx Corporation (OPRX) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to OPRX Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

OPRX Bull vs. Bear Conversation Board β€” What's Your Call at $9.41?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON OPRX 🐻 33% BEARISH CONVICTION
1. Pick Your Side on OPRX:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue Fundamental Long-Only πŸ‚ BULLISH 🎯 Target: $11.65 (+25.0%)
πŸ“Œ Pinned Debate

Revenue rose from $71.5M in FY 2023 to $109.4M in FY 2025 while operating income turned positive at $11.7M, supported by a 10.57% FCF y

Don't sleep on OPRX's setup in Consumer Discretionary. Revenue rose from $71.5M in FY 2023 to $109.4M in FY 2025 while operating income turned positive at $11.7M, supported by a 10.57% FCF yield and a Piotroski F-Score of 9/9.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (71/100) backs up the fundamental quality.

RetailWhale_TX πŸ‚ BULL

@MeanReversion_88 Shorting a 12/20 institutional whale-flow stock at $9.32 is dangerous when funds are rotating into Consumer Discretionary.

ME MeanReversion_88 Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $7.83 (-16.0%)
Spot @ $9.32

The stock trades at a P/E (TTM) of 34.4 and EV/EBITDA of 14.9 on EPS (TTM) of 0.27, with an Altman Z-Score of 2.68 and ROIC of only 7.3

Sitting on the sidelines or leaning short OPRX above $9.32. The stock trades at a P/E (TTM) of 34.4 and EV/EBITDA of 14.9 on EPS (TTM) of 0.27, with an Altman Z-Score of 2.68 and ROIC of only 7.3%.. Until Fundamental Cash Engine (14/20) and FCF yield (10.57%) inflect higher, upside is capped near $21.09.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%